Holdings
Invesco Health Care Fund
As of Jul 31, 2026, Invesco Health Care Fund reported 78 positions worth US$1.18B. Largest: Eli Lilly and Company, Johnson & Johnson and UnitedHealth Group Incorporated. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Eli Lilly and Company | 111K | US$128M | −5,504 | Jul 31, 2026 |
| Johnson & Johnson | 318K | US$81.6M | +30,790 | Jul 31, 2026 |
| UnitedHealth Group Incorporated | 180K | US$74.4M | +63,953 | Jul 31, 2026 |
| Merck & Company, Inc. | 426K | US$55.4M | +191K | Jul 31, 2026 |
| AbbVie Inc. | 194K | US$48.6M | no change | Jul 31, 2026 |
| Gilead Sciences, Inc. | 337K | US$43.9M | no change | Jul 31, 2026 |
| argenx SE | 45,770 | US$39.1M | −7,206 | Jul 31, 2026 |
| CVS Health Corporation | 291K | US$30.4M | +66,820 | Jul 31, 2026 |
| Welltower Inc. | 120K | US$28.2M | no change | Jul 31, 2026 |
| BrightSpring Health Services, Inc. | 445K | US$26.5M | −37,560 | Jul 31, 2026 |